N/A
Completed N=495
Effectiveness of the Propeller Health (Formerly Asthmapolis) Monitoring System
Source: ClinicalTrials.gov NCT01509183 ↗Enrolled (actual)
495
Serious AEs
0.0%
Results posted
Feb 2018
Primary outcomePrimary: Change in Mean SABA Use — -0.41; -0.31 mean puffs per day
Summary
Propeller Health is collaborating with Dignity Health (formerly Catholic Healthcare West (CHW)) to carry out a focused demonstration project to evaluate the effectiveness and potential cost savings of a deployment of the Propeller Health approach to asthma management. The Propeller Health goal is to bring together the best technology and asthma insight in order to provide Dignity Health with an engaging, data-driven chronic care program to improve asthma management and lower healthcare utilization costs, and to respond to prevention-focused reforms to health insurance laws.
This project has been designed to implement and evaluate a data-driven program to improve asthma management and control and lower direct costs through reductions in healthcare utilization. This program has been developed by Propeller Health and has gone through preliminary testing. Each subject participating in the study will receive an Propeller Health device, which captures the time and location of use of inhaled short-acting bronchodilators over a twelve-month period. This information is processed and delivered at regular intervals to the patient and his or her provider to support improved asthma management.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Change in Mean SABA Use |
-0.41; -0.31 | — |
| SECONDARY Change in the Proportion of SABA-free Days From Baseline to 12 Months |
21; 17 | — |
Eligibility Criteria
Inclusion Criteria
- Provider diagnosis of asthma (ICD9 493.xx);
- At least one healthcare utilization event in CHW within last 12 months; and
- Prescription for Short Acting Beta Agonist (SABA) at study intake.
Exclusion Criteria
- Subject is under the age of 5 at the beginning of the study;
- Subject does not speak either English or Spanish;
- Subject does not have access to the Internet or email to receive reports; and
- Subject has substantial co-morbidity (provider diagnosis of COPD
Data sourced from ClinicalTrials.gov (NCT01509183). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.